Metoprolol for the Prevention of Acute Exacerbations of COPD | Zendy

Mark T. Dransfield | Zendy; Helen Voelker | Zendy; Surya P. Bhatt | Zendy; Keith Brenner | Zendy; Richard Casaburi | Zendy; Carolyn E. Come | Zendy; John A. Cooper | Zendy; Gerard J. Criner | Zendy; Jeffrey L. Curtis | Zendy; MeiLan K. Han | Zendy; Umur Hatipoğlu | Zendy; Erika S. Helgeson | Zendy; Vipul V. Jain | Zendy; Ravi Kalhan | Zendy; David A. Kaminsky | Zendy; Robert J. Kaner | Zendy; Ken M. Kunisaki | Zendy; Allison Lambert | Zendy; Matthew R. Lammi | Zendy; Sarah Lindberg | Zendy; Barry J. Make | Zendy; Fernando J. Martínez | Zendy; Charlene McEvoy | Zendy; Ralph J. Panos | Zendy; Robert M. Reed | Zendy; Paul D. Scanlon | Zendy; Frank C. Sciurba | Zendy; Anthony Smith | Zendy; Peruvemba Sriram | Zendy; William W. Stringer | Zendy; Jeremy A. Weingarten | Zendy; J. Michael Wells | Zendy; Elizabeth Westfall | Zendy; Stephen C. Lazarus | Zendy; John E. Connett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metoprolol for the Prevention of Acute Exacerbations of COPD

Author(s) -

Mark T. Dransfield,

Helen Voelker,

Surya P. Bhatt,

Keith Brenner,

Richard Casaburi,

Carolyn E. Come,

John A. Cooper,

Gerard J. Criner,

Jeffrey L. Curtis,

MeiLan K. Han,

Umur Hatipoğlu,

Erika S. Helgeson,

Vipul V. Jain,

Ravi Kalhan,

David A. Kaminsky,

Robert J. Kaner,

Ken M. Kunisaki,

Allison Lambert,

Matthew R. Lammi,

Sarah Lindberg,

Barry J. Make,

Fernando J. Martínez,

Charlene McEvoy,

Ralph J. Panos,

Robert M. Reed,

Paul D. Scanlon,

Frank C. Sciurba,

Anthony Smith,

Peruvemba Sriram,

William W. Stringer,

Jeremy A. Weingarten,

J. Michael Wells,

Elizabeth Westfall,

Stephen C. Lazarus,

John E. Connett

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1908142

Subject(s) - copd , medicine , observational study , pulmonary disease , randomized controlled trial , metoprolol , intensive care medicine , emergency medicine

Observational studies suggest that beta-blockers may reduce the risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary disease (COPD), but these findings have not been confirmed in randomized trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research